癌症中心血培养瓶短缺期间血培养利用与管束实践的影响
2024年全球血培养瓶短缺期间,某三级癌症中心实施诊断管束干预,包括停用持续发热医嘱集、修改新发热医嘱集推荐初始两套血培养、发布修订指南并反复教育。与2023年同期相比,血培养利用率下降36.3%(从14,021降至8,932),检测患者数相近,血培养阳性率(排除污染)呈上升趋势(7.1% vs 7.6%,P=0.08),脓毒症编码 encounters 和30天死亡率相似,未报告相关不良结局。
要点
- 诊断管束干预使血培养利用率下降36.3%,患者数相近。
- 干预后血培养阳性率(排除污染)呈上升趋势(7.1% vs 7.6%,P=0.08)。
- 脓毒症编码 encounters 和30天死亡率无差异,未报告不良结局。
核心结论
- 在高复杂度癌症患者人群中,通过限制初始血培养数量和取消持续发热的预防性血培养医嘱,可实现血培养利用率显著下降且无负面临床影响。
研究设计与样本
- 回顾性前后干预研究,比较2024年血培养瓶短缺5个月期间与2023年同期未受影响5个月期间,在独立癌症中心进行。
主要发现
- 血培养利用率下降36.3%(从14,021降至8,932),检测患者数相近。
- 住院 encounters 和随访血培养的利用率下降最大。
- 干预后血培养阳性率(排除潜在污染)呈上升趋势(7.1% vs 7.6%,P=0.08)。
- 脓毒症编码 encounters 频率和30天死亡率在两个时期相似。
- 未报告与血培养管束相关的不良结局。
关键数值与推荐
- 干预措施包括停用持续发热的医嘱集、修改新发热医嘱集推荐初始两套血培养、发布修订血培养医嘱指南并对提供者、采血员和护士反复教育。
临床怎么用
- 在免疫抑制患者中实施血培养诊断管束时,可限制初始血培养数量并取消持续发热的预防性医嘱,以安全降低利用率。
局限性
- 回顾性研究设计,单中心,干预期间存在血培养瓶短缺背景,可能影响普适性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Formulating safe and effective diagnostic stewardship guidance for blood cultures in immunocompromised patients is challenging due to limited data and high risk of infectious complications. A 2024 global shortage in blood culture bottles (BD Diagnostics) necessitated the implementation of blood culture stewardship, including at our tertiary care cancer center. This was a retrospective pre-post intervention study of the effects of diagnostic stewardship at a stand-alone cancer center during a 5-month period of the 2024 blood culture bottle shortage compared to the same 5-month unaffected period in 2023. Interventions included discontinuation of an ordering set for persistent fever, modification of an ordering set for new fever to recommend two sets of blood cultures for initial workup, and issuing revised blood culture ordering guidance to providers, phlebotomists, and nurses with repeated educational efforts. Stewardship interventions led to decreased blood culture utilization by 36.3% (from 14,021 to 8,932), while the number of patients tested remained similar. Greatest reductions in utilization occurred in inpatient encounters and with follow-up blood cultures. There was a trend toward increasing blood culture positivity following intervention, excluding potential contaminants (7.1% vs 7.6%, P = 0.08). The frequency of sepsis-coded encounters and 30-day mortality rate were similar between the two time periods. No adverse outcomes related to blood culture stewardship were reported. A significant reduction in blood culture utilization is achievable in a high-complexity cancer patient population without negative clinical impact through limiting the number of initial blood cultures and eliminating pre-emptive ordering of blood culture orders for persistent fever.IMPORTANCECancer and transplant patient populations are frequently excluded from experimental studies on decreasing blood culture utilization, but a recent global supply shortage in blood culture bottles provided a valuable opportunity to evaluate the effects of stewardship interventions on a large scale. This study, centered on a high-complexity cancer patient population, found that a significant 36.3% reduction in blood culture utilization was achievable, safe, and effective through multidisciplinary diagnostic stewardship efforts.
引用
- She RC, Bender JM, Pullarkat V, et al. Blood culture utilization and impact of stewardship practices during a national blood culture bottle shortage at a cancer center. J Clin Microbiol. 2025. PMID: 41358753. doi:10.1128/jcm.01160-25
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。